These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 35401564)
1. A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma. Zhao M; Shen S; Xue C Front Immunol; 2022; 13():805967. PubMed ID: 35401564 [TBL] [Abstract][Full Text] [Related]
2. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma. Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D Front Immunol; 2022; 13():918140. PubMed ID: 35833147 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma. Xiao Y; Li J; Wu J BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171 [TBL] [Abstract][Full Text] [Related]
4. Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer. Ren M; Fan B; Cao G; Zong R; Feng L; Sun H BMC Genomics; 2023 Dec; 24(1):776. PubMed ID: 38097948 [TBL] [Abstract][Full Text] [Related]
5. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma. Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654 [TBL] [Abstract][Full Text] [Related]
6. m Wu Y; Li L; Wang L; Zhang S; Zeng Z; Lu J; Wang Z; Zhang Y; Zhang S; Li H; Chen T BMC Cancer; 2024 Apr; 24(1):506. PubMed ID: 38649860 [TBL] [Abstract][Full Text] [Related]
7. A m Xu S; Zhang Y; Yang Y; Dong K; Zhang H; Luo C; Liu SM Front Immunol; 2024; 15():1374465. PubMed ID: 39119345 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive characterization of m6A methylation and its impact on prognosis, genome instability, and tumor microenvironment in hepatocellular carcinoma. Yin T; Zhao L; Yao S BMC Med Genomics; 2022 Mar; 15(1):53. PubMed ID: 35260168 [TBL] [Abstract][Full Text] [Related]
9. The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma. Liu T; Sun L; Li ZZ; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P BMC Gastroenterol; 2023 May; 23(1):147. PubMed ID: 37170222 [TBL] [Abstract][Full Text] [Related]
10. m1A Regulatory gene signatures are associated with certain immune cell compositions of the tumor microenvironment and predict survival in kidney renal clear cell carcinoma. Zhou L; Zhou W; Li Y; Hua R Eur J Med Res; 2023 Sep; 28(1):321. PubMed ID: 37679761 [TBL] [Abstract][Full Text] [Related]
11. Gene signatures and prognostic values of m1A-related regulatory genes in hepatocellular carcinoma. Shi Q; Xue C; Yuan X; He Y; Yu Z Sci Rep; 2020 Sep; 10(1):15083. PubMed ID: 32934298 [TBL] [Abstract][Full Text] [Related]
12. The Impact of m1A Methylation Modification Patterns on Tumor Immune Microenvironment and Prognosis in Oral Squamous Cell Carcinoma. Gao L; Chen R; Sugimoto M; Mizuta M; Kishimoto Y; Omori K Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638642 [TBL] [Abstract][Full Text] [Related]
13. Deciphering the Divergent Gene Expression Landscapes of m6A/m5C/m1A Methylation Regulators in Hepatocellular Carcinoma Through Single-Cell and Bulk RNA Transcriptomic Analysis. Liu HT; Rau CS; Liu YW; Hsieh TM; Huang CY; Chien PC; Lin HP; Wu CJ; Chuang PC; Hsieh CH J Hepatocell Carcinoma; 2023; 10():2383-2395. PubMed ID: 38164510 [TBL] [Abstract][Full Text] [Related]
14. Hypoxic Characteristic in the Immunosuppressive Microenvironment of Hepatocellular Carcinoma. Mo Z; Liu D; Rong D; Zhang S Front Immunol; 2021; 12():611058. PubMed ID: 33679749 [No Abstract] [Full Text] [Related]
15. Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinoma. Chen D; Aierken A; Li H; Chen R; Ren L; Wang K Front Immunol; 2023; 14():1232390. PubMed ID: 37881434 [TBL] [Abstract][Full Text] [Related]
16. Identification and analysis of necroptosis-associated signatures for prognostic and immune microenvironment evaluation in hepatocellular carcinoma. Lu J; Yu C; Bao Q; Zhang X; Wang J Front Immunol; 2022; 13():973649. PubMed ID: 36081504 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of the Function, Immune Profiles, and Clinical Implication of m1A Regulators in Lung Adenocarcinoma. Bao G; Li T; Guan X; Yao Y; Liang J; Xiang Y; Zhong X Front Oncol; 2022; 12():882292. PubMed ID: 35712502 [TBL] [Abstract][Full Text] [Related]
18. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma. Huang S; Sun L; Hou P; Liu K; Wu J Front Immunol; 2022; 13():944898. PubMed ID: 36148220 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer. Liu J; Chen C; Wang Y; Qian C; Wei J; Xing Y; Bai J Front Immunol; 2021; 12():746647. PubMed ID: 34777359 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the m6A/m1A/m5C/m7G-related regulators on the prognosis and immune microenvironment of glioma by integrated analysis of scRNA-seq and bulk RNA-seq data. Yang L; Huang Z; Deng Y; Zhang X; Lv Z; Huang H; Sun Q; Liu H; Liang H; He B; Hu F J Gene Med; 2024 Feb; 26(2):e3666. PubMed ID: 38391150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]